AI Portfolio Summary
In 2025 Q4, Tetragon Partners GP Ltd maintained a portfolio of 53 distinct positions. The most significant new addition to the portfolio was PRAXIS PRECISION MED, which now represents 1.43% of the total fund value. They heavily accumulated shares in UIPATH INC, increasing their position by 2.9%. Conversely, Tetragon Partners GP Ltd completely exited their position in ALIBABA GROUP HLDG L.
Total Positions
53
Quarter
2025 Q4
Top Holding
PATH (60.3%)
Top 10 Concentration
86.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 53
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PATH
UIPATH INC
|
Technology | 60.30% | 30.33% |
#1
Prev: #1
|
10.0 | 500,000 | 2.9% |
P
S
|
17,450,000 | $286,005,500 | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KGEI
KOLIBRI GLOBAL ...
|
Energy | 5.75% | 5.24% |
#2
2
Prev: #4
|
2.3 | -136,064 | -1.9% |
P
S
|
6,934,504 | $27,252,601 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LYFT
LYFT INC
|
Technology | 4.08% | 2.94% |
#3
3
Prev: #6
|
1.6 | no change | no change |
P
S
|
1,000,000 | $19,370,000 | 2019 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AUTL
AUTOLUS THERAPE...
|
Healthcare | 3.99% | 2.07% |
#4
7
Prev: #11
|
1.6 | no change | no change |
P
S
|
9,500,000 | $18,905,000 | 2018 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CXM
SPRINKLR INC
|
Technology | 3.61% | 2.27% |
#5
5
Prev: #10
|
1.4 | no change | no change |
P
S
|
2,200,000 | $17,116,000 | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WK
WORKIVA INC
|
Technology | 2.73% | 1.73% |
#6
6
Prev: #12
|
1.1 | no change | no change |
P
S
|
150,000 | $12,937,500 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ANNX
ANNEXON INC
|
Healthcare | 2.15% | 0.86% |
#7
10
Prev: #17
|
0.9 | -80,000 | -3.8% |
P
S
|
2,032,455 | $10,202,924 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 1.43% | — |
#8
Prev: #—
|
2.6 | 22,952 | no change |
NEW
|
22,952 | $6,764,872 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 1.40% | 1.05% |
#9
5
Prev: #14
|
0.6 | -59,800 | -19.7% |
P
S
|
243,800 | $6,621,608 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 1.36% | 0.38% |
#10
17
Prev: #27
|
2.6 | 15,094 | 18.4% |
P
S
|
96,935 | $6,435,515 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 1.14% | 0.65% |
#11
9
Prev: #20
|
0.5 | no change | no change |
P
S
|
194,612 | $5,400,483 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 1.04% | 0.75% |
#12
7
Prev: #19
|
0.5 | -19,522 | -42.0% |
P
S
|
26,934 | $4,919,226 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 1.02% | 0.38% |
#13
13
Prev: #26
|
2.4 | 24,816 | 11.1% |
P
S
|
247,997 | $4,850,821 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 0.95% | 0.42% |
#14
10
Prev: #24
|
0.4 | -34,513 | -19.4% |
P
S
|
143,327 | $4,520,534 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RAPT
RAPT THERAPEUTI...
|
Healthcare | 0.94% | — |
#15
Prev: #—
|
2.4 | 131,770 | no change |
NEW
|
131,770 | $4,463,050 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 0.93% | — |
#16
Prev: #—
|
2.4 | 162,018 | no change |
NEW
|
162,018 | $4,410,130 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 0.89% | 0.41% |
#17
8
Prev: #25
|
0.4 | -22,192 | -11.8% |
P
S
|
166,187 | $4,224,474 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 0.83% | 0.36% |
#18
10
Prev: #28
|
2.5 | 51,560 | 57.5% |
P
S
|
141,172 | $3,949,993 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FOLD
AMICUS THERAPEU...
|
Healthcare | 0.78% | 0.13% |
#19
16
Prev: #35
|
2.6 | 139,559 | 115.1% |
P
S
|
260,771 | $3,713,379 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 0.69% | 0.47% |
#20
3
Prev: #23
|
2.3 | 14,586 | 5.6% |
P
S
|
272,828 | $3,295,762 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HRMY
HARMONY BIOSCIE...
|
Healthcare | 0.65% | — |
#21
Prev: #—
|
2.3 | 82,824 | no change |
NEW
|
82,824 | $3,099,274 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 0.62% | — |
#22
Prev: #—
|
2.2 | 69,287 | no change |
NEW
|
69,287 | $2,929,454 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 0.61% | 0.11% |
#23
13
Prev: #36
|
2.5 | 6,944 | 142.6% |
P
S
|
11,814 | $2,912,624 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MPLT
MAPLIGHT THERAP...
|
Healthcare | 0.61% | — |
#24
Prev: #—
|
2.2 | 164,525 | no change |
NEW
|
164,525 | $2,889,882 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SLN
SILENCE THERAPE...
|
Healthcare | 0.47% | — |
#25
Prev: #—
|
2.2 | 365,369 | no change |
NEW
|
365,369 | $2,221,444 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
ALIBABA GROUP H...
|
—
|
Bond/Debt | 0.00% | 23.39% |
Sold All 😨
(Was: #2) |
0.3 | -95,000,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
HYG
PUT
ISHARES TR
|
PUT Option | 0.00% | 7.89% |
Sold All 😨
(Was: #3) |
0.3 | -726,900 | -100.0% |
CLOSED
|
— | $— | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
LITHIUM ARGENTI...
|
—
|
Bond/Debt | 0.00% | 3.29% |
Sold All 😨
(Was: #5) |
0.3 | -27,109,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
N/A
CABLE ONE INC
|
—
|
Bond/Debt | 0.00% | 2.78% |
Sold All 😨
(Was: #7) |
0.3 | -21,255,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
N/A
PROGRESS SOFTWA...
|
—
|
Bond/Debt | 0.00% | 2.75% |
Sold All 😨
(Was: #8) |
0.3 | -20,500,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
N/A
OATLY GROUP AB
|
—
|
Bond/Debt | 0.00% | 2.46% |
Sold All 😨
(Was: #9) |
0.3 | -20,020,027 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
N/A
FIRST MAJESTIC ...
|
—
|
Bond/Debt | 0.00% | 1.07% |
Sold All 😨
(Was: #13) |
0.3 | -7,500,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
N/A
CELCUITY INC
|
—
|
Bond/Debt | 0.00% | 1.00% |
Sold All 😨
(Was: #15) |
0.3 | -5,550,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 0.00% | 0.99% |
Sold All 😨
(Was: #16) |
0.3 | -125,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HYG
ISHARES TR
|
ETF | 0.00% | 0.79% |
Sold All 😨
(Was: #18) |
0.3 | -72,961 | -100.0% |
CLOSED
|
— | $— | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 0.00% | 0.59% |
Sold All 😨
(Was: #21) |
0.3 | -117,882 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TECX
TECTONIC THERAP...
|
Healthcare | 0.00% | 0.51% |
Sold All 😨
(Was: #22) |
0.3 | -243,728 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABVX
ABIVAX SA
|
Healthcare | 0.00% | 0.34% |
Sold All 😨
(Was: #29) |
0.3 | -30,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 0.00% | 0.25% |
Sold All 😨
(Was: #31) |
0.3 | -86,071 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HBM
HUDBAY MINERALS...
|
Basic Materials | 0.00% | 0.24% |
Sold All 😨
(Was: #32) |
0.3 | -117,500 | -100.0% |
CLOSED
|
— | $— | 2015 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CCJ
CAMECO CORP
|
Energy | 0.00% | 0.18% |
Sold All 😨
(Was: #33) |
0.3 | -16,015 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 0.00% | 0.16% |
Sold All 😨
(Was: #34) |
0.3 | -223,123 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TECK
TECK RESOURCES ...
|
Basic Materials | 0.00% | 0.11% |
Sold All 😨
(Was: #37) |
0.3 | -18,068 | -100.0% |
CLOSED
|
— | $— | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KROS
KEROS THERAPEUT...
|
Healthcare | 0.00% | 0.09% |
Sold All 😨
(Was: #38) |
0.3 | -43,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LAR
LITHIUM ARGENTI...
|
Basic Materials | 0.00% | 0.09% |
Sold All 😨
(Was: #39) |
0.3 | -200,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 0.00% | 0.07% |
Sold All 😨
(Was: #40) |
0.3 | -17,718 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WB
WATERBRIDGE INF...
|
Communication Services | 0.00% | 0.07% |
Sold All 😨
(Was: #41) |
0.3 | -20,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NXE
NEXGEN ENERGY L...
|
Energy | 0.00% | 0.05% |
Sold All 😨
(Was: #42) |
0.3 | -42,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DSX/WS
DIANA SHIPPING ...
|
Unknown | 0.00% | 0.00% |
Sold All 😨
(Was: #43) |
0.3 | -233,400 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SONDW
SONDER HOLDINGS...
|
Unknown | 0.00% | 0.00% |
Sold All 😨
(Was: #44) |
0.3 | -18,898 | -100.0% |
CLOSED
|
— | $— | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 53 holdings